4 years ago

Treatment with Doxycycline is Associated with Reduced Spleen Size in Hyper-Reactive Malarial Splenomegaly: A Cohort Study

Peter John Barnard Davies, Simon Eyre

Background:

Hyper-reactive malarial splenomegaly (HMS)is a poorly understood sequela of chronic parasitaemia, caused by an aberrant immune response, and confers a high associated mortality. There arefew historical data on effective treatments, which are either unavailable or unaffordable in endemic areas. In Kagando, Western Uganda patients were treated with Doxycycline and followed up to measure the effect.

Methods:

Patients were identified by medical officers from March 2018 at Kagando Hospital who met Fakunle's criteria for HMS; children under 12 years and pregnant women were excluded. The baseline full blood count and splenic size from the costal margin was measured and manually recorded. Patients were discharged with a 6-monthcourse of Doxycycline and asked to attend on completion for follow-up assessment. Spleenmeasurements and compliance wererecorded by medical officers, before being tabulated and analysed electronically.

Results:

In total 27 patients were treated for HMS over a two year period with 7 patients returning for a follow up between 6-15 months. The median age was 36 years with a near equal male to female ratio. Prior to treatment patients displayed a variable degree of pancytopenia with a median haemoglobin of 10.1, leucocytes 4.5 and platelets 82, and the median spleen size was 16cm from the costal margin. The Wilcoxon signed-rank test was used for statistical analysis. There was a significant reduction in spleen size p<0.05, with 4/7 showing complete resolution. There was a numericalimprovement in platelet count (median82 vs 125) p=0.16.

Conclusions:

Regular doxycycline use as malaria prophylaxis in a holoendemic area of Uganda was associated with a significant reduction in spleen size and a numerical improvement in platelet count. A larger cohort study and an improved follow-up regime is required to further characterise this effect. However, doxycyclineprovidesa practical and affordable treatment modality in a rural Ugandan population, with no current national or international guidelines. In some patients the benefit is seen up to a year from treatment completion.

Open access
You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.